€27.26
0.27% today
Xetra, Oct 15, 05:35 pm CET
ISIN
DE000BAY0017
Symbol
BAYN

Bayer Stock price

€27.26
-0.25 0.89% 1M
+6.43 30.88% 6M
+7.94 41.12% YTD
+0.73 2.73% 1Y
-22.97 45.73% 3Y
-16.86 38.21% 5Y
-81.80 75.01% 10Y
-1.31 4.57% 20Y
Xetra, Closing price Wed, Oct 15 2025
-0.08 0.27%
ISIN
DE000BAY0017
Symbol
BAYN
Industry

Key metrics

Basic
Market capitalization
€27.3b
Enterprise Value
€60.2b
Net debt
€32.9b
Cash
€5.5b
Shares outstanding
982.4m
Valuation (TTM | estimate)
P/E
negative | 5.8
P/S
0.6 | 0.6
EV/Sales
1.3 | 1.3
EV/FCF
13.1
P/B
0.9
Dividends
DPS
€0.11
Yield 1Y | 5Y
0.4% | 2.7%
Growth 1Y | 5Y
0.0% | -47.7%
Payout 1Y | 3Y
-4.2% | -191.2%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€46.2b | €46.7b
EBITDA
€6.6b | €9.5b
EBIT
€-1.4b | €6.1b
Net Income
€-3.4b | €4.7b
Free Cash Flow
€4.6b
Growth (TTM | estimate)
Revenue
-2.0% | 0.2%
EBITDA
-32.8% | -25.8%
EBIT
-161.1% | 53.0%
Net Income
-170.0% | 282.8%
Free Cash Flow
-19.3%
Margin (TTM | estimate)
Gross
55.0%
EBITDA
14.3% | 20.3%
EBIT
-2.9%
Net
-7.4% | 10.0%
Free Cash Flow
9.9%
Financial Health
Equity Ratio
28.8%
Return on Equity
-8.0%
ROCE
-1.8%
ROIC
-1.8%
Debt/Equity
1.3
More
EPS
€-3.5
FCF per Share
€4.7
Short interest
-
Employees
91k
Rev per Employee
€510.0k
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Bayer forecast:

12x Buy
43%
15x Hold
54%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Bayer forecast:

Buy
43%
Hold
54%
Sell
4%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
46,174 46,174
2% 2%
100%
- Direct Costs 20,802 20,802
5% 5%
45%
25,372 25,372
7% 7%
55%
- Selling and Administrative Expenses 15,312 15,312
2% 2%
33%
- Research and Development Expense 6,150 6,150
12% 12%
13%
6,623 6,623
33% 33%
14%
- Depreciation and Amortization 7,974 7,974
4% 4%
17%
EBIT (Operating Income) EBIT -1,351 -1,351
161% 161%
-3%
Net Profit -3,418 -3,418
170% 170%
-7%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

Positive
Seeking Alpha
6 days ago
Bayer Aktiengesellschaft remains deeply undervalued despite ongoing business struggles and litigation headwinds, with significant upside potential if challenges are resolved. Bayer's Q2 '25 results were mediocre, but the company raised 2025 guidance and is making progress on litigation settlements, aiming for containment by the end of 2026. The turnaround strategy includes workforce reductions,...
Neutral
Business Wire
8 days ago
ORLANDO, Fla.--(BUSINESS WIRE)-- #BiotechNews--Hesperos, Inc. (Hesperos), a global leader focused on improving preclinical drug development, food, cosmetic, and chemical testing with its Human-on-a-Chip® (HoaC) single- and multi-organ systems platform, is pleased to announce the publication of a new peer-reviewed study, developed in collaboration with Bayer Consumer Health. The study introduces...
Neutral
Business Wire
8 days ago
ST. LOUIS--(BUSINESS WIRE)--Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest and the only ForwardFarm in the United States. This recognition places Cornfed Farms as one of 16 farms around the globe, highlighted by Bayer as committed to advancing regenerative agriculture pra...
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 90,587
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today